Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinoma

Masahiro Nozawa,Koichi Sugimoto,Takayuki Ohzeki,Takafumi Minami,Nobutaka Shimizu,Shogo Adomi,Yoshitaka Saito,Kazuhiro Nose,Kazuhiro Yoshimura,Hirotsugu Uemura

Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinoma

2016

Masahiro Nozawa
Koichi Sugimoto
Takayuki Ohzeki
Takafumi Minami
Nobutaka Shimizu
Shogo Adomi
Yoshitaka Saito
Kazuhiro Nose
Kazuhiro Yoshimura
Hirotsugu Uemura

Background No report has evaluated axitinib-induced proteinuria as a biomarker for predicting treatment efficacy and survival of patients with metastatic renal cell carcinoma (mRCC).

Keywords:

Urology
Axitinib
Proteinuria
Renal cell carcinoma
Biomarker (medicine)
Diabetes mellitus
Medicine
in patient
Surgical oncology
Internal medicine
Retrospective cohort study
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations